Avidity Biosciences Insider Sold Shares Worth $2,121,045, According to a Recent SEC Filing

Michael F MacLean, Chief Financial Officer, on May 14, 2024, sold 75,000 shares in Avidity Biosciences (RNA) for $2,121,045. Following the Form 4 filing with the SEC, MacLean has control over a total

MT NewswiresMay 17 03:24 ET

Avidity Biosciences(RNA.US) Officer Sells US$2.12 Million in Common Stock

$Avidity Biosciences(RNA.US)$ Officer MacLean Michael F sold 75,000 shares of common stock on May 14, 2024 at an average price of $28.2806 for a total value of $2.12 million.Source: Announcement What

moomoo NewsMay 16 19:05 ET

Express News | Avidity Biosciences Announces Appointment of Simona Skerjanec to Board of Directors

ReutersMay 15 09:00 ET

Form 144 | Avidity Biosciences(RNA.US) Officer Proposes to Sell 1.95 Million in Common Stocks

SEC FILLINGS DISCLOSED/ May 14, $Avidity Biosciences(RNA.US)$ Officer MICHAEL MACLEAN intends to sell 75,000 shares of its common stock on May 14, with a total market value of approximately $1.95 mill

moomoo NewsMay 14 16:28 ET

Vicore Expands and Strengthens Its Board of Directors

STOCKHOLM, SWEDEN / ACCESSWIRE / May 14, 2024 / Vicore Pharma Holding Stockholm, May 14, 2024 - Vicore Pharma Holding AB, a clinical-stage biopharmaceutical company unlocking the potential of a new class of

AccesswireMay 14 02:20 ET

Avidity Biosciences: Strong Buy on Promising Trials and Solid Financials

TipRanksMay 13 06:22 ET